151 related articles for article (PubMed ID: 30290787)
1. Association between acromegaly and a single nucleotide polymorphism (rs2854744) in the IGFBP3 gene.
Gao M; Zhu B; Xu Z; Liu S; Liu J; Zhang G; Gao Y; Fan Y; Kang X
BMC Med Genet; 2018 Oct; 19(1):182. PubMed ID: 30290787
[TBL] [Abstract][Full Text] [Related]
2. Influence of the
Gao M; Zhu B; Li P; Zhang G; Chen K; Lv H; Ma R; Zhang L; Fan Y; Kang X
Front Endocrinol (Lausanne); 2018; 9():751. PubMed ID: 30619084
[No Abstract] [Full Text] [Related]
3. Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments.
Ramos-Leví AM; Marazuela M; Paniagua A; Quinteiro C; Riveiro J; Álvarez-Escolá C; Lúcas T; Blanco C; de Miguel P; Martínez de Icaya P; Pavón I; Bernabeu I
Eur J Endocrinol; 2015 Feb; 172(2):115-22. PubMed ID: 25385818
[TBL] [Abstract][Full Text] [Related]
4. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly.
Jallad RS; Trarbach EB; Duarte FH; Jorge AA; Bronstein MD
Pituitary; 2015 Oct; 18(5):666-73. PubMed ID: 25552351
[TBL] [Abstract][Full Text] [Related]
5. IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly.
Akin F; Turgut S; Cirak B; Kursunluoglu R
Growth Horm IGF Res; 2010 Dec; 20(6):399-403. PubMed ID: 20920870
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP2 and IGFBP3 Genotypes, Haplotypes, and Genetic Models Studies in Polycystic Ovary Syndrome.
Govahi Kakhki F; Sargazi S; Montazerifar F; Majidpour M; Karajibani A; Karajibani M; Ghasemi M
J Clin Lab Anal; 2024 Mar; 38(5):e25021. PubMed ID: 38468402
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
8. Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene.
Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Lukas C; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2012 Feb; 86(2):195-203. PubMed ID: 21892705
[TBL] [Abstract][Full Text] [Related]
9. Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer.
Ma X; Kang H; Dai Z; Ma L; Jin Y; Wang X
Biomed Pharmacother; 2015 Apr; 71():108-11. PubMed ID: 25960224
[TBL] [Abstract][Full Text] [Related]
10. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
Park K; Kim JH; Jeon HG; Byun SS; Lee E
Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding protein 3 promoter variant (rs2854744) is associated with nonalcoholic fatty liver disease.
Mahmoudi T; Nouri S; Zarei F; Najafabadi ZN; Sanei M; Sayedsalehi S; Rezamand G; Asadi A; Dabiri R; Nobakht H; Farahani H; Tabaeian SP; Zali MR
Arch Endocrinol Metab; 2023 Nov; 68():e230017. PubMed ID: 37948568
[TBL] [Abstract][Full Text] [Related]
12. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
Safarinejad MR; Shafiei N; Safarinejad SH
Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
[TBL] [Abstract][Full Text] [Related]
13. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
[TBL] [Abstract][Full Text] [Related]
14. Insulinlike Growth Factor-1 and Its Binding Protein-3 Polymorphisms Predict Circulating IGF-1 Level and Appendicular Skeletal Muscle Mass in Chinese Elderly.
Yang CW; Li TC; Li CI; Liu CS; Lin CH; Lin WY; Lin CC
J Am Med Dir Assoc; 2015 May; 16(5):365-70. PubMed ID: 25548030
[TBL] [Abstract][Full Text] [Related]
15. Role of polymorphisms of the IGF2 and IGFBP3 genes and risk of gastric carcinoma in China.
Gu J; Li M; Dong P; Lu J; Tan Z; Wu X; Mu J; Zhang L; Wu W; Ding Q; Yang J; Cao Y; Ding Q; Weng H; Liu Y
Chin Med J (Engl); 2014; 127(3):412-6. PubMed ID: 24451943
[TBL] [Abstract][Full Text] [Related]
16. Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents.
Mong JL; Ng MC; Guldan GS; Tam CH; Lee HM; Ma RC; So WY; Wong GW; Kong AP; Chan JC; Waye MM
Int J Obes (Lond); 2009 Dec; 33(12):1446-53. PubMed ID: 19786971
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
18. Associations of IGFBP3 Gene Polymorphism and Gene Expression with the Risk of Osteonecrosis of the Femoral Head in a Han Population in Northern China.
Song Y; Du Z; Yang Q; Ren M; Sui Y; Wang Q; Wang A; Zhao H; Wang J; Zhang G
DNA Cell Biol; 2016 Dec; 35(12):836-844. PubMed ID: 27704894
[TBL] [Abstract][Full Text] [Related]
19. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]